News

Early study: Potential ‘functional cure’ for AIDS?

View on the News

‘Elegant science’ with uncertain future

The only way this is really going to be useful is if they in fact completely replace normal T cells ultimately, because as long as you have normal cells getting infected and spitting out virus, you’ve got a problem, and you’ve got a problem because normal cells making virus give you that immune activation that’s a very deleterious part of HIV disease – the aberrant activation associated with virus replication.

Is this elegant science? Yes. Is it an important step in the right direction? Yes. Will this turn out to be a successful approach? I can’t tell you that right now. It might not be.

Dr. Anthony S. Fauci is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.


 

FROM CROI 2014

Is this elegant science? Yes. Is it an important step in the right direction? Yes. Will this turn out to be a successful approach? I can’t tell you that right now. It might not be.

Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

Pages

Recommended Reading

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host
MDedge Internal Medicine
ACIP balks at recommending LAIV
MDedge Internal Medicine
Campus meningitis outbreaks tamed but can our approach last?
MDedge Internal Medicine
Be wary of a ‘penicillin allergy’ history in hospitalized patients
MDedge Internal Medicine
FDA vaccines panel: Retain current strains in next season’s influenza vaccines
MDedge Internal Medicine
HHS proposes new targets for HAI reduction
MDedge Internal Medicine
CDC sounds alarm on hospital antibiotic use
MDedge Internal Medicine
New drugs trump interferon in HCV therapy
MDedge Internal Medicine
HIV-1 has gained virulence over the course of the epidemic
MDedge Internal Medicine
Risk of condomless sex low if HIV-positive partner is well controlled on ART
MDedge Internal Medicine